Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (3): 249-253.DOI: 10.3969/j.issn.1673-8640.2022.03.012
Previous Articles Next Articles
Received:2020-09-02
Revised:2021-04-02
Online:2022-03-30
Published:2022-05-10
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.03.012
| 组别 | 例数 | RBC计数/（×1012/L） | Hb/（g/L） | HCT/% | RDW-s/fL | RDW-CV/% | MPV/fL |
|---|---|---|---|---|---|---|---|
| 总样本 | 2 967 | 4.84±0.69 | 147.1±24.9 | 44.16±6.87 | 42.44±3.69 | 13.34±1.48 | 9.33±1.20 |
| 男性 | 1 476 | 5.53±0.59 | 162.7±22.9 | 48.03±6.28 | 42.84±3.98 | 13.17±1.23 | 9.43±1.12 |
| 女性 | 1 491 | 4.94±0.61 | 144.5±19.9 | 41.41±5.55 | 41.89±3.19 | 13.51±1.72 | 9.22±1.26 |
| 儿童组 | 507 | 5.29±0.53* | 138.8±17.7* | 42.32±4.74* | 42.21±6.54 | 13.65±1.39* | 8.76±0.89* |
| 男性 | 256 | 5.32±0.56 | 138.3±17.9 | 42.06±4.50 | 44.46±6.78# | 14.10±1.41# | 8.71±0.93 |
| 女性 | 251 | 5.24±0.47 | 139.7±17.5 | 42.74±5.12 | 37.70±2.81 | 12.75±0.88 | 8.83±0.84 |
| 少年组 | 693 | 5.23±0.49* | 149.9±15.9* | 44.26±4.75 | 41.26±4.29 | 13.88±1.63* | 9.45±1.04 |
| 男性 | 344 | 5.35±0.52# | 153.3±14.9# | 45.29±5.01# | 40.63±5.08# | 14.03±1.86# | 9.45±1.02 |
| 女性 | 349 | 5.11±0.43 | 146.8±16.2 | 43.31±4.30 | 42.40±2.39 | 13.64±1.34 | 9.45±1.07 |
| 青年组 | 1 218 | 5.12±0.73* | 150.3±26.6* | 43.96±7.32 | 42.66±3.15 | 13.25±1.44 | 9.43±1.31 |
| 男性 | 602 | 5.71±0.48# | 173.9±16.8# | 51.02±4.42# | 43.29±3.35# | 12.88±0.83# | 9.76±1.09# |
| 女性 | 616 | 4.79±0.63 | 142.3±17.2 | 39.94±5.33 | 42.07±2.87 | 13.46±1.67 | 9.24±1.39 |
| 中年组 | 421 | 5.38±0.62* | 162.1±25.2* | 47.80±7.48* | 42.56±3.05 | 13.18±1.82 | 9.35±1.21 |
| 男性 | 212 | 5.60±0.61# | 177.1±17.8# | 51.71±5.98# | 42.23±2.93# | 12.62±0.81# | 9.46±1.17 |
| 女性 | 209 | 5.10±0.55 | 146.9±18.4 | 43.09±6.31 | 44.70±3.50 | 13.80±1.83 | 9.21±1.25 |
| 老年组 | 128 | 5.45±1.07* | 166.0±28.9* | 48.72±8.73* | 42.77±1.64 | 12.58±0.68* | 9.06±1.23 |
| 男性 | 62 | 5.71±1.13# | 171.7±24.0# | 51.70±9.21# | 42.65±2.07 | 12.90±0.71# | 9.14±1.10 |
| 女性 | 66 | 5.01±0.83 | 147.3±14.1 | 43.51±4.72 | 43.01±1.34 | 12.10±0.51 | 8.92±1.48 |
| 组别 | 例数 | RBC计数/（×1012/L） | Hb/（g/L） | HCT/% | RDW-s/fL | RDW-CV/% | MPV/fL |
|---|---|---|---|---|---|---|---|
| 总样本 | 2 967 | 4.84±0.69 | 147.1±24.9 | 44.16±6.87 | 42.44±3.69 | 13.34±1.48 | 9.33±1.20 |
| 男性 | 1 476 | 5.53±0.59 | 162.7±22.9 | 48.03±6.28 | 42.84±3.98 | 13.17±1.23 | 9.43±1.12 |
| 女性 | 1 491 | 4.94±0.61 | 144.5±19.9 | 41.41±5.55 | 41.89±3.19 | 13.51±1.72 | 9.22±1.26 |
| 儿童组 | 507 | 5.29±0.53* | 138.8±17.7* | 42.32±4.74* | 42.21±6.54 | 13.65±1.39* | 8.76±0.89* |
| 男性 | 256 | 5.32±0.56 | 138.3±17.9 | 42.06±4.50 | 44.46±6.78# | 14.10±1.41# | 8.71±0.93 |
| 女性 | 251 | 5.24±0.47 | 139.7±17.5 | 42.74±5.12 | 37.70±2.81 | 12.75±0.88 | 8.83±0.84 |
| 少年组 | 693 | 5.23±0.49* | 149.9±15.9* | 44.26±4.75 | 41.26±4.29 | 13.88±1.63* | 9.45±1.04 |
| 男性 | 344 | 5.35±0.52# | 153.3±14.9# | 45.29±5.01# | 40.63±5.08# | 14.03±1.86# | 9.45±1.02 |
| 女性 | 349 | 5.11±0.43 | 146.8±16.2 | 43.31±4.30 | 42.40±2.39 | 13.64±1.34 | 9.45±1.07 |
| 青年组 | 1 218 | 5.12±0.73* | 150.3±26.6* | 43.96±7.32 | 42.66±3.15 | 13.25±1.44 | 9.43±1.31 |
| 男性 | 602 | 5.71±0.48# | 173.9±16.8# | 51.02±4.42# | 43.29±3.35# | 12.88±0.83# | 9.76±1.09# |
| 女性 | 616 | 4.79±0.63 | 142.3±17.2 | 39.94±5.33 | 42.07±2.87 | 13.46±1.67 | 9.24±1.39 |
| 中年组 | 421 | 5.38±0.62* | 162.1±25.2* | 47.80±7.48* | 42.56±3.05 | 13.18±1.82 | 9.35±1.21 |
| 男性 | 212 | 5.60±0.61# | 177.1±17.8# | 51.71±5.98# | 42.23±2.93# | 12.62±0.81# | 9.46±1.17 |
| 女性 | 209 | 5.10±0.55 | 146.9±18.4 | 43.09±6.31 | 44.70±3.50 | 13.80±1.83 | 9.21±1.25 |
| 老年组 | 128 | 5.45±1.07* | 166.0±28.9* | 48.72±8.73* | 42.77±1.64 | 12.58±0.68* | 9.06±1.23 |
| 男性 | 62 | 5.71±1.13# | 171.7±24.0# | 51.70±9.21# | 42.65±2.07 | 12.90±0.71# | 9.14±1.10 |
| 女性 | 66 | 5.01±0.83 | 147.3±14.1 | 43.51±4.72 | 43.01±1.34 | 12.10±0.51 | 8.92±1.48 |
| 项目 | RBC计数 | Hb | HCT | RDW-s | RDW-CV | MPV |
|---|---|---|---|---|---|---|
| 与总样本x比较 | 100.00 | 100.00 | 60.00 | 20.00 | 60.00 | 20.00 |
| 各组不同性别比较 | 80.00 | 80.00 | 80.00 | 80.00 | 100.00 | 20.00 |
| 各组同性别比较 | 62.50 | 50.00 | 50.00 | 75.00 | 50.00 | 37.50 |
| 项目 | RBC计数 | Hb | HCT | RDW-s | RDW-CV | MPV |
|---|---|---|---|---|---|---|
| 与总样本x比较 | 100.00 | 100.00 | 60.00 | 20.00 | 60.00 | 20.00 |
| 各组不同性别比较 | 80.00 | 80.00 | 80.00 | 80.00 | 100.00 | 20.00 |
| 各组同性别比较 | 62.50 | 50.00 | 50.00 | 75.00 | 50.00 | 37.50 |
| 组别 | RBC计数/（×1012/L） | Hb/（g/L） | HCT/% | RDW-s/fL | RDW-CV/% | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | |||||
| 总样本 | ||||||||||||||
| 男性 | 4.37~6.69 | 4.30~ 5.80 | 117.9~207.6 | 130.0~ 175.0 | 35.7~60.4 | 35.0~50.7 | 10.8~15.6 | |||||||
| 女性 | 3.74~6.14 | 3.80~ 5.10 | 105.5~183.6 | 115.0~ 150.0 | 30.5~52.3 | 35.6~48.1 | 10.1~16.9 | |||||||
| 儿童组 | ||||||||||||||
| 男性 | 4.23~6.41 | 4.00~ 4.50 | 103.1~173.5 | 120.0~ 140.0 | 33.2~50.9 | 31.2~57.8 | 11.3~16.9 | |||||||
| 女性 | 4.31~6.16 | 4.00~ 4.50 | 105.5~173.9 | 120.0~ 140.0 | 32.7~52.8 | 32.2~43.2 | 11.0~14.5 | |||||||
| 少年组 | ||||||||||||||
| 男性 | 4.33~6.38 | 123.9~182.6 | 35.5~55.1 | 40.00~ 50.00 | 30.7~50.6 | 35.00~ 56.00① | 10.4~17.7 | 11.00~ 16.00① | ||||||
| 女性 | 4.26~5.96 | 115.0~178.6 | 34.9~51.7 | 35.00~ 45.00 | 37.7~47.1 | 35.00~ 56.00① | 11.0~16.3 | 11.00~ 16.00① | ||||||
| 青年组 | ||||||||||||||
| 男性 | 4.78~6.65 | 141.0~206.8 | 42.3~59.7 | 36.7~49.9 | 11.3~14.5 | |||||||||
| 女性 | 3.55~6.03 | 108.5~176.1 | 29.5~50.4 | 36.4~47.7 | 10.2~16.7 | |||||||||
| 中年组 | ||||||||||||||
| 男性 | 4.42~6.79 | 142.3~211.9 | 40.0~63.4 | 36.5~48.0 | 11.0~14.2 | |||||||||
| 女性 | 4.02~6.19 | 110.9~182.8 | 30.7~55.4 | 37.8~51.6 | 10.2~17.4 | |||||||||
| 老年组 | ||||||||||||||
| 男性 | 3.49~7.92 | 124.7~218.8 | 33.7~69.8 | 38.6~46.7 | 11.5~14.3 | |||||||||
| 女性 | 3.38~6.62 | 119.5~175.0 | 34.3~52.8 | 41.9~44.1 | 11.6~12.7 | |||||||||
| 组别 | RBC计数/（×1012/L） | Hb/（g/L） | HCT/% | RDW-s/fL | RDW-CV/% | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | 本研究 | 操作 规程 | |||||
| 总样本 | ||||||||||||||
| 男性 | 4.37~6.69 | 4.30~ 5.80 | 117.9~207.6 | 130.0~ 175.0 | 35.7~60.4 | 35.0~50.7 | 10.8~15.6 | |||||||
| 女性 | 3.74~6.14 | 3.80~ 5.10 | 105.5~183.6 | 115.0~ 150.0 | 30.5~52.3 | 35.6~48.1 | 10.1~16.9 | |||||||
| 儿童组 | ||||||||||||||
| 男性 | 4.23~6.41 | 4.00~ 4.50 | 103.1~173.5 | 120.0~ 140.0 | 33.2~50.9 | 31.2~57.8 | 11.3~16.9 | |||||||
| 女性 | 4.31~6.16 | 4.00~ 4.50 | 105.5~173.9 | 120.0~ 140.0 | 32.7~52.8 | 32.2~43.2 | 11.0~14.5 | |||||||
| 少年组 | ||||||||||||||
| 男性 | 4.33~6.38 | 123.9~182.6 | 35.5~55.1 | 40.00~ 50.00 | 30.7~50.6 | 35.00~ 56.00① | 10.4~17.7 | 11.00~ 16.00① | ||||||
| 女性 | 4.26~5.96 | 115.0~178.6 | 34.9~51.7 | 35.00~ 45.00 | 37.7~47.1 | 35.00~ 56.00① | 11.0~16.3 | 11.00~ 16.00① | ||||||
| 青年组 | ||||||||||||||
| 男性 | 4.78~6.65 | 141.0~206.8 | 42.3~59.7 | 36.7~49.9 | 11.3~14.5 | |||||||||
| 女性 | 3.55~6.03 | 108.5~176.1 | 29.5~50.4 | 36.4~47.7 | 10.2~16.7 | |||||||||
| 中年组 | ||||||||||||||
| 男性 | 4.42~6.79 | 142.3~211.9 | 40.0~63.4 | 36.5~48.0 | 11.0~14.2 | |||||||||
| 女性 | 4.02~6.19 | 110.9~182.8 | 30.7~55.4 | 37.8~51.6 | 10.2~17.4 | |||||||||
| 老年组 | ||||||||||||||
| 男性 | 3.49~7.92 | 124.7~218.8 | 33.7~69.8 | 38.6~46.7 | 11.5~14.3 | |||||||||
| 女性 | 3.38~6.62 | 119.5~175.0 | 34.3~52.8 | 41.9~44.1 | 11.6~12.7 | |||||||||
| [1] | 王治国. 临床检验生物学变异与参考区间[M]. 北京: 人民卫生出版社, 2012. |
| [2] | 中华人民共和国卫生部. WS/T 405-2012 血细胞分析参考区间[S]. 北京:中华人民共和国卫生部, 2012. |
| [3] | 尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015. |
| [4] | 谢玉海, 王学军. 高原地区患者术前凝血功能特征及血栓弹力图评估凝血功能的价值研究[J]. 中国现代医学杂志, 2017, 27(17):80-83. |
| [5] | 吴显熠, 张中伟, 吴小冬, 等. 高原不同人群体外红细胞无氧酵解能力的差异[J]. 西部医学, 2018, 30(7):952-955. |
| [6] | 丁宁, 陈长强, 樊绮诗. 红细胞分布宽度、血清总胆红素与冠心病及冠状动脉病变程度相关性研究[J]. 检验医学, 2019, 34(10):889-893. |
| [7] |
REXHAJ E, RIMOLDI S F, PRATALI L, et al. Sleep-disordered breathing and vascular function in patients with chronic mountain sickness and healthy high-altitude dwellers[J]. Chest, 2016, 149(4):991-998.
DOI URL |
| [8] | 李熙建, 谭扬, 谭同均, 等. 高原地区不同年龄人群血细胞参数的分层与对比研究[J]. 重庆医科大学学报, 2020, 45(10):1491-1496. |
| [9] | 刘佳丽, 王薇, 何法霖, 等. 全国110家妇幼保健院及儿童医院检验科儿童全血细胞计数参考区间调查与分析[J]. 中华检验医学杂志, 2019, 42(4):277-281. |
| [10] | 刘国雄, 刘勇, 刘韵丽, 等. 红原县健康藏族成人静脉血血细胞参数参考区间研究[J]. 检验医学, 2019, 34(5):437-440. |
| [11] | ZHANG H, HE Y, CUI C, et al. Cross-altitude analysis suggests a turning point at the elevation of 4 500 m for polycythemia prevalence in Tibetans[J]. Am J Hematol, 2017, 92(9):E552-E554. |
| [12] | 张致英, 张寒, 刘丽军, 等. 高原红细胞增多症相关蛋白因子和基因的研究进展[J]. 国外医学(医学地理分册), 2019, 40(2):204-208. |
| [13] |
LIU Y S, HUANG H, ZHOU S M, et al. Excessive iron availability caused by disorders of interleukin-10 and interleukin-22 contributes to high altitude polycythemia[J]. Front Physiol, 2018, 9:548.
DOI URL |
| [14] | Clinical and Laboratory Standards Institute. Method comparison and bias estimation using patient samples[S]. EP9-A2,CLSI, 2002. |
| [15] | Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI, 2010. |
| [16] | 中华人民共和国卫生部. WS/T 402-2012 临床实验室检验项目参考区间的制定[S]. 北京:中华人民共和国卫生部, 2012. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
